InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.60
(
-0.22%
)
Bitcoin
65,207.13
(
0.11%
)

Replies to post #170484 on Biotech Values

Replies to #170484 on Biotech Values

jq1234

11/25/13 1:37 PM

#170487 RE: genisi #170484

CBST/CXA201 in cUTI: It is actually superior to levofloxacin even though it is a non-inferiority trial, 95% CI = 2.3%, 14.6%.

Result from another ph3 in cIAI will be in late Dec.